Skip to main content
U.K. Edition
Thursday, 2 May 2024

National Donate Life Month

Credit: WTAT
Duration: 0 shares 1 views

National Donate Life Month
National Donate Life Month
National Donate Life Month

>> welcome back, and talking about donate life month, and we just chanted with a pharmaceutical doctor about new technology on the medicinal side of transplantation, and here to talk to us about transplant outcomes is dr. rohan, from usmc.

And thank you so much for joining us.

>> thank you.

>> first, let's start with how things are currently done in terms of before surgery and after surgery when it comes to organ transplantation.

Do you do any kinds of therapies to make sure that someone is healthy before they receive their new organ so they can continue along within a healthy body tore support that new organ?

>> so most of our patients, they are sick, because they are in organ failure.

So we rarely ever get a healthy transplant recipient.

Rarely.

We end up getting more and more sick people, so our goal is to make them healthy from being very sick.

So trying to get patients healthy sometimes becomes very difficult because they don't have a functioning organ.

>> so getting someone on the right track once they receive a new organ, opioids have been deadly for a lot of people who become addicted to them, so you want to minimize opioids in the process.

How are you doing that and what are you replacing it with?

>> it might be modality, pain control approach.

So that we can decrease the opioid.

>> i see, and enhanced recovery after surgery with virtual followup, living donors, and what does that entail?

>> so living donors are our -- somebody who is going to go ahead and donate for their loved ones, and some of them are altruistic donors, and our aim of doing the surgery, so that the patients can recover as quickly as possible, and they have a smoot post-operative recovery phase, so oftentimes, recovering after surgery, the patients where we do mortality therapy, with the operative patient, optimization, interoperative phase, we do the mortality therapy, and it's very well controlled.

And then we follow the patients post-on regularly, and in the post on phase, we try to make sure that the patients have early they start taking back early enough, and so that the patient's recovery is much quicker, and we also have this initiative a lot of them are patients that come from out of state, and with the followup, we do that locally, and we can secure the connections, and do a phenomenal up on the patient.

>> and living in a world now with covid-19, and doctor, i want to thank you so much for sharing all of that information with us, and we'll be looking forward to new research as well emerging from usmc.

Thank you so much for join us today.

Back after this.

You might like

Related news coverage

Advertisement

More coverage